Secondary Metabolites and Biotherapeutics Developments in Applied Microbiology and Biotechnology Series

Secondary Metabolites and Biotherapeutics presents the latest biotechnological advancements in the production of target secondary metabolites for medicinal use, including topics such as transcriptomics, nanotechnology, gene editing tools like CRISPR/CAS, secondary metabolites source and production.? Secondary metabolites derived from plants as a response to stress have always played a vital role in the pharmaceutical industry to produce medicines. However, their limited production in plants have always raised concerns for large-scale production. With the advancement of modern biotechnology, researchers around the globe are now able to engineer plants with specific chemical compositions.

This book is a valuable resource to researchers in biotechnology, medical sciences, pharmaceutical biotechnology, pharmacology and plant biology.

Dr. Awanish Kumar is currently an Associate Professor in the Department of Biotechnology at the National Institute of Technology, Raipur (CG), India. He is working in the area of infection biology, drug targeting, and drug discovery. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute-Lucknow, India and Jawaharlal Nehru University-Delhi, India. He did his post-doctoral study at McGill University, Montreal, Canada. Dr. Kumar has served various national and international organizations in different academic and research capacities. He has authored several monographs, books, and book chapters. He has served on many national committees, scientific society and advisory panels, is a member of many international professional research societies and as a reviewer and editorial board member of reputed and refereed journals.
Dr. Sunil Kumar is currently an Associate Professor at the Shri Ramswaroop Memorial University, Barabanki (Uttar Pradesh) India. His research interests include genetic engineering, molecular biology; medical microbiology particularly focused on molecular characterization of bacterial biofilm and drug development and inflammatory bowel diseases. Dr. Kumar has authored more than 40 peer-reviewed articles, 15 book chapters and edited one book for springer. Dr. Kumar serves as an editorial board member and reviewer of more than 6 international journals.